Tag: drug development
Phebra partners with University of Wollongong to develop drug for leukemia, pancreatic cancer
Australian pharmaceutical firm Phebra and the University of Wollongong (UOW) have entered into a six-year collaboration agreement to carry out research and development (R&D) and trials of patented and targeted arsenic compounds for the treatment of acute myeloid leukemias and pancreatic cancer.
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
